59 related articles for article (PubMed ID: 17657053)
1. Mycological and serological study of pulmonary aspergillosis in central India.
Kurhade AM; Deshmukh JM; Fule RP; Chande C; Akulwar S
Indian J Med Microbiol; 2002; 20(3):141-4. PubMed ID: 17657053
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of aspergillosis in bronchogenic carcinoma.
Malik A; Shahid M; Bhargava R
Indian J Pathol Microbiol; 2003 Jul; 46(3):507-10. PubMed ID: 15025326
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
Kaya AD; Kiraz N
Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Aspergillosis in chronic lung diseases.
Shahid M; Malik A; Bhargava R
Indian J Med Microbiol; 2001; 19(4):201-5. PubMed ID: 17664833
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
[TBL] [Abstract][Full Text] [Related]
6. The effect of antifungal agents and human monocytes on in vitro galactomannan release by Aspergillus spp. in liquid culture medium.
Winn RM; Warris A; Gaustad P; Abrahamsen TG
APMIS; 2007 Dec; 115(12):1364-9. PubMed ID: 18184406
[TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
8. [Aspergillus serum precipitins in patients of a lung clinic].
Mishra SK; Staib F; Krumhaar D; Steffen J; Voigt R; Abel T
Dtsch Med Wochenschr; 1976 Sep; 101(38):1377-81. PubMed ID: 821738
[TBL] [Abstract][Full Text] [Related]
9. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.
Walsh TJ; Petraitis V; Petraitiene R; Field-Ridley A; Sutton D; Ghannoum M; Sein T; Schaufele R; Peter J; Bacher J; Casler H; Armstrong D; Espinel-Ingroff A; Rinaldi MG; Lyman CA
J Infect Dis; 2003 Jul; 188(2):305-19. PubMed ID: 12854088
[TBL] [Abstract][Full Text] [Related]
10. [Aspergillus spp. isolations from respiratory tract samples in Trakya University Hospital].
Gürcan S; Demir M; Altiay G; Tikveşli M; Kiliç H; Otkun M
Tuberk Toraks; 2007; 55(2):160-6. PubMed ID: 17602344
[TBL] [Abstract][Full Text] [Related]
11. [Sero-diagnosis for pulmonary aspergillosis--its utility in early diagnosis].
Niki Y
Rinsho Byori; 1996 Jun; 44(6):518-23. PubMed ID: 8752728
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma.
Chen J; Li H; Li R; Bu D; Wan Z
J Antimicrob Chemother; 2005 Jan; 55(1):31-7. PubMed ID: 15563516
[TBL] [Abstract][Full Text] [Related]
13. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli.
Lionakis MS; Lewis RE; Torres HA; Albert ND; Raad II; Kontoyiannis DP
Diagn Microbiol Infect Dis; 2005 May; 52(1):15-20. PubMed ID: 15878437
[TBL] [Abstract][Full Text] [Related]
14. Fungal spectrum identified by a new slide culture and in vitro drug susceptibility using Etest in fungal keratitis.
Qiu WY; Yao YF; Zhu YF; Zhang YM; Zhou P; Jin YQ; Zhang B
Curr Eye Res; 2005 Dec; 30(12):1113-20. PubMed ID: 16354625
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of mycologic and myco-serologic studies of materials derived from the respiratory tract of patients in the years 1986-1990].
Budak A; Trojanowska D; Niedzin J; Prokop A
Med Dosw Mikrobiol; 1993; 45(2):259-62. PubMed ID: 8309310
[TBL] [Abstract][Full Text] [Related]
16. Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.
Paterson PJ; Seaton S; Prentice HG; Kibbler CC
J Antimicrob Chemother; 2003 Nov; 52(5):873-6. PubMed ID: 14519673
[TBL] [Abstract][Full Text] [Related]
17. Bronchogenic carcinoma and secondary aspergillosis--common yet unexplored: evaluation of the role of bronchoalveolar lavage-polymerase chain reaction and some nonvalidated serologic methods to establish early diagnosis.
Shahid M; Malik A; Bhargava R
Cancer; 2008 Aug; 113(3):547-58. PubMed ID: 18521930
[TBL] [Abstract][Full Text] [Related]
18. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
Hüseyin A; Sancak B; Arikan S
Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710
[TBL] [Abstract][Full Text] [Related]
19. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
Warn PA; Morrissey G; Morrissey J; Denning DW
J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility to five antifungals of Aspergillus fumigatus strains isolated from chronically colonised cystic fibrosis patients receiving azole therapy.
Amorim A; Guedes-Vaz L; Araujo R
Int J Antimicrob Agents; 2010 Apr; 35(4):396-9. PubMed ID: 20138740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
